Lilly    4Q Revenues: $6.0 billion (-1%) 4Q Earnings: $827.2 million (-4%) YTD Revenues: $22.6 billion (-7%)  YTD Earnings: $4.1 billion (-6%) Comments: Revenue in the U.S. was down 2% to $3.2 billion and revenue outside the U.S. was down 1% to $2.7 billion. Revenue decline included a 3% decrease due to lower volume, driven by the loss of patent exclusivity for Zyprexa in most major markets (-49% to $384.8 million), and 1% due to the unfavorable effect of foreign exchange rates. Humulin sale...